This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wondering what happens if you use expired semaglutide? For one, it can make the medication less effective — and in rare cases, it ...
Please provide your email address to receive an email when new articles are posted on . Semaglutide 7.2 mg reduced body weight vs. placebo in patients with obesity regardless of diabetes status. There ...
Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...
Two important studies based on the largest and longest clinical trial of the effects of semaglutide on weight in over 17,000 adults with overweight and obesity but not diabetes find patients lost on ...
Semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease regardless of baseline adiposity. Cardiovascular benefit was largely ...
Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema) for weight ...
MALAGA, Spain—In a head-to-head battle between two drugs that reduce body weight, the newer kid on the block, perhaps not unexpectedly, came out on top. The SURMOUNT-5 trial, published over the ...
Millions of people with obesity avoid treatment because current GLP-1 drugs are only available as injections. Results from a Phase 3 trial show that a daily oral pill version of semaglutide from Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results